Tag Archives: research

Bridging Research to Cures: Summit for R&D Companies

admin-ajax copy

As human and animal health companies struggle to advance medical innovation while managing costs, the outsourcing of research and development functions has become a critical strategy for success. BioResearch Central provides the outsourcing resources needed to accelerate healthcare innovation, to reach patients faster. Born of the legacy of Marion Laboratories and supported by a highly experienced workforce, BioResearch Central companies provide a breadth of services including discovery, toxicology, bioanalytics, clinical trials, regulatory and commercial support. Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Kansas City Area Summit Brings together CROs

admin-ajax copy

The Kansas City region is home to 200 life science companies employing more than 20,000 people on both sides of the state line. Those kind of numbers put the area on the map as being a significant industry leading hub for drug development, diagnostics, clinical research, and animal health. Amid this growing biotech industry hub are 90 contract research organization, or CROs as we call them, which provide research services outsourced on a contract basis. Read More >

Events  |  3 Comments  |  Email This Post
Tags: , , , ,

Make Medical Research a National Priority

maryheadshotbw

Biomedical and health research fuels private sector innovation and the development of new therapies and devices to prevent and fight disease. Funding cuts threaten scientific discoveries that could lead to new therapies and potential cures for deadly disease. In recent months, thought leaders in medical research have taken their message public to demonstrate the medical, economic and competitive advantages of government investment in research. We must reinforce the message to members of Congress during the Read More >

Health  |  1 Comment  |  Email This Post
Tags: , , , , , , , , ,

How to Survive the Patent Cliff: Eli Lilly’s CEO at the BIO CEO & Investor Conference

Fireside Chat

Like a number of companies, Eli Lilly is confronting a wave of patent expirations called the patent cliff. The company lost U.S. patent protection on the anti-psychotic Zyprexa in the fall of 2011 and they’re facing the losses of the antidepressant Cymbalta in December of 2013 and the osteoporosis drug Evista in 2014. The loss of protection endangers the company’s ability to profit from the drugs and they could face a $25 billion loss in Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Poster Session at BIO’s World Congress Showcases Cutting Edge Research

World Congress

BIO’s 10th Annual World Congress on Industrial Biotechnology taking place this June in Montreal will feature a poster session highlighting cutting edge research in industrial biotech. Professors, students, scientists and industry reps are all encouraged to submit posters detailing their research that could lead to the next big breakthrough. Numerous poster submissions have already come in and it’s looking to be a banner year in research. One poster describes a novel pretreatment process using oxalic acid Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , ,